Novavax, Inc. - Common Stock (NQ:NVAX)

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who...

2 Growth Stocks with Explosive Upside and 1 That Underwhelm

January 15, 2026

Novavax Inc (NASDAQ:NVAX) shares are trading higher. Reports show a rise in respiratory illnesses across the United States.

Trump’s Iran Tariff Threat Lit a Fuse Under Oil — and Wall Street Still Sold It ↗

January 14, 2026

Via Chartmill

Topics Government

CORRECTED: Why Is Novavax Stock Soaring? ↗

January 13, 2026

Via Benzinga

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

An Overview of Novavax's Earnings ↗

November 05, 2025

Via Benzinga

Nasdaq, S&P 500 Futures Wobble As Trump-Powell Clash Rattles Markets: Why CRML, HIMS, WMT, NFLX, NVAX, COF Are On Traders' Radar Today ↗

January 12, 2026

Looking back on therapeutics stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Novavax (NASDAQ:NVAX) and its peers.

Topics Stocks

Q3 Earnings Outperformers: Novavax (NASDAQ:NVAX) And The Rest Of The Therapeutics Stocks

January 04, 2026

Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 3% in the morning session after reports revealed that its JN.1 Covid-19 vaccine became available at some GP clinics in Singapore.

Topics Artificial Intelligence

Novavax (NVAX) Stock Trades Up, Here Is Why

January 02, 2026

Vaccine biotechnology company Novavax (NASDAQ:NVAX) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 16.6% year on year to $70.45 million. The company expects the full year’s...

Topics Artificial Intelligence

Novavax (NASDAQ:NVAX) Surprises With Q3 CY2025 Sales

January 01, 2026

In a blockbuster conclusion to the 2025 trading year, Dynavax Technologies (NASDAQ:DVAX) saw its stock price skyrocket by nearly 40% in premarket trading this morning, December 24, 2025. The surge...

Topics Artificial Intelligence

Sanofi Acquires Dynavax in $2.2 Billion Christmas Eve Deal, Sending Shares Soaring

December 24, 2025

Via MarketMinute

Topics Intellectual Property

Why I Wouldn't Touch Novavax With a 10-Foot Pole ↗

December 11, 2025

This stock could be a wealth destroyer in the next five years.

Via The Motley Fool

Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths ↗

December 01, 2025

Moderna tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children.

Novavax Stock Faces Retail Backlash As Shah Capital Warns Of Proxy Fight And Presses For A Sale ↗

Topics Death

November 12, 2025

Shah Capital increased its stake to about 8.3% and said the gap between Novavax’s scientific potential and its commercial results has become “striking.”

The company recently expanded on its Sanofi partnership to include its Matrix-M adjuvant in Sanofi’s pandemic influenza vaccine candidate program.

Novavax Sees Higher Revenue From Partners For Full-Year, Raises Revenue Guidance ↗

November 06, 2025

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.

Top Stocks With Earnings This Week: Joby, IonQ, AMD and More ↗

November 03, 2025

Via Benzinga

AI Stocks Slide Again, Bitcoin Dips Near $100,000: What's Moving Markets Thursday? ↗

November 06, 2025

After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto...

Via Benzinga

Topics Artificial Intelligence

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential ↗

October 14, 2025

Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least $5 billion.

Via Benzinga

Novavax Major Shareholder Calls For Sale Of Company To Larger Pharma Entity ↗

October 14, 2025

Shah Capital currently owns 11.8 million shares or 7.2% of Novavax.

ConnectM Exits Nasdaq for OTCQB Venture Market: A Deep Dive into Delisting, Challenges, and a Path Forward

October 02, 2025

ConnectM Technology Solutions (OTCQB: CMMU), a company specializing in green energy technology, has officially transitioned its trading to the OTCQB Venture Market, effective October 2, 2025, following...

Via MarketMinute

Topics Artificial Intelligence Economy

India's Tech Ascent: A 'Mission Mode' for Global Leadership in Semiconductors, Quantum, AI, and Biomanufacturing

October 01, 2025

India is embarking on an ambitious "mission mode" strategy, signaling a profound shift in its national policy to establish itself as a global leader in critical and emerging technologies. This...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Novavax Amends Deal With Sanofi, Broadens Partnership ↗

September 30, 2025

The amendment of the agreement allows for the use of Matrix-M in early-stage development of Sanofi's pandemic influenza vaccine candidate.

Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough' ↗

September 26, 2025

Rep. Haley Stevens (D-Mich.) announced that she will introduce articles of impeachment against Health and Human Services Secretary Robert F. Kennedy Jr.

Via Benzinga

Trump Advises Parents To Split Vaccines, Delay Hepatitis B Shots Until Age 12: 'This Is Based On What I Feel' ↗

September 22, 2025

President Donald Trump on Monday offered advice on childhood vaccination schedules, encouraging parents to split up certain immunizations and delay certain others, in sharp contradiction to current...

Via Benzinga

Topics Government

CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids ↗

September 19, 2025

Moderna stock toppled Friday after advisors to the CDC and Prevention ended the universal recommendation for Covid vaccines.

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?' ↗

September 18, 2025

Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps,...

Via Benzinga

The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut ↗

September 18, 2025

The reworked ACIP will make its debut Friday when the panelists weigh the suite of new Covid boosters.

Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots ↗

Topics Government

September 15, 2025

Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices, just days...

Via Benzinga

FDA Moves To Publicize Data On Pregnant Women's Covid Vaccine Side Effects ↗

September 10, 2025

Top health officials under Kennedy are pushing for more transparency on Covid vaccine risks, focusing on pregnant women and child deaths, amid disputes with GOP lawmakers and industry leaders.

Via Benzinga

Topics Death

Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.? ↗

September 05, 2025

It's unprecedented times for the Covid vaccine market, experts say. And Pfizer and Moderna remain under significant pressure.